Stockreport

Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR [Y...

Trinity Capital Inc.  (TRIN) 
PDF damage during structural heart procedures such as transcatheter aortic valve replacement (TAVR), today announced it has closed $20 Million in growth capital from Trinity [Read more]